Todd C. Davis, CEO: Ligand Pharmaceuticals LGND Buy · Filed 25/05/13

Trade details

Type: Insider buy
Amount: $583,615.41
Shares · price: 5,523 sh · $105.67 a share
Held after: 161,234 sh
Stock: Ligand Pharmaceuticals LGND
Person: Todd C. DavisCEO
Trade date: 25/05/09
Filed: 25/05/13
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +3.5%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/09~25/06/08

Todd C. Davis's recent trades

Todd C. DavisDirector
BuyPelthos Therapeutics
Buy
Pelthos Therapeutics
PTHS
$985.4K
35,445 sh
$985.4K
Filed 06/15
Traded 06/11
Todd C. DavisDirector
BuyPelthos Therapeutics
Buy
Pelthos Therapeutics
PTHS
$14.5K
503 sh
$14.5K
Filed 06/15
Traded 06/11
Todd C. DavisCEO
BuyLigand Pharmaceuticals
Buy
Ligand Pharmaceuticals
LGND
$241.2K
2,307 sh
$241.2K
Filed 25/05/13
Traded 25/05/09
Todd C. DavisCEO
BuyLigand Pharmaceuticals
Buy
Ligand Pharmaceuticals
LGND
$175.7K
1,680 sh
$175.7K
Filed 25/05/13
Traded 25/05/09
Todd C. DavisCEO
BuyLigand Pharmaceuticals
Buy
Ligand Pharmaceuticals
LGND
$243.5K
2,500 sh
$243.5K
Filed 24/08/09
Traded 24/08/08

Todd C. Davis, CEO — bought $583.6K of Ligand Pharmaceuticals LGND · 5,523 sh @ $105.67 | Whalegun